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Clinical Observations 
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Objective: To study the effect of acupuncture on depression and insomnia of malignant tumor patients.  
Methods: Eighty cases of cancer related depression and sleep disorders were randomly divided into 2 groups: 
treatmentl group (acupuncture n=40) and control group (Fluoxetione n=40). All patients were assessed by 
Self-rating Depression Scale (SDS), Hemilton Depression Rating Scale (HAMD) and Pittsburgh Sleep Quality 
Index (PSQI) after treatment for 30 days.  
Results: Before treatment the SDS and HAMD scores of the trial group were 64.12±5.34 and 20.92±2.38, those of 
the control group were 64.24±4.98 and 20.72±2.74, after treatment the SDS and HAMD scores of the trial group 
were 43.64±5.28 and 9.88±1.27 respectively, significantly lower than those of the control group (50.76±5.42 and 
13.72±2.05 respectively, both P<0.05). Before treatment the PSQI score of the trial group and the control group 
were 14.48±1.71 and13.92±2.59, after treatment the PSQI score of the trial group was 7.92±1.22 after treatment, 
significantly lower than those of the control group (11.44f1.89, P<0.01). 
Conclusion: Acupuncture can effectively reduce malignant-related depression, improve sleep quality, and help to 
improve the quality of life of cancer patients.  
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The existing researches indicate that most patients 
suffering from malignant tumor have the problem of 
depression with the incidence rate of 10%–25%.1,2 And 
their daily life conditions such as sleep quality and  
appetite are closely related to the depressed mood.3 In 
treating depression and sleep disorder, acupuncture has 
unique effect. The authors observed the therapeutic 
effects for depression and sleep quality of patients 
suffering from malignant tumor with pattern of 
phlegm-stasis binding. The results are as follows. 
METHODS 
General Data 
Totally 80 patients suffering from malignant tumor were 
selected from both the outpatient and inpatient ward of 
Traditional Chinese Medicine (TCM) Department or 
Acupuncture Department of Chinese PLA General 
Hospital from October 2008 to October 2010. They were 
divided into treatment and control groups by random 
digits table with 40 patients in each group. The study was 
approved by the Ethical Committee of General Hospital 
of PLA, and all the patients signed the informed consent 
forms before treatment. Between the two groups, there 
was no statistical difference in gender, age and tumor 
type (P>0.05), thus they had comparability in the trial 
(Table 1, 2, 3). 
Diagnostic Criteria 
1. Diagnostic criteria of Western medicine: Depression 
occurs after the malignant tumor, and the depression 
meets the related standard of Chinese Classification and 
Diagnostic Criteria of Mental Disorders, 3rd ed, 
(CCMD-3).4  
2. Diagnostic criteria of phlegm-stasis binding: the 
disease is caused by phlegm-stasis binding with the 
following symptoms: stuffy pain in chest,5,6 abdominal 
lumps and fullness or fixed stabbing pain, somber face 
and blue-green lips, sticky feeling in the mouth and lack 
of taste sensation, poor appetite and digestion, distention 
in the stomach duct, severe palpitations, yellow greasy 
coating, purple dusky tongue or with purple plague, or 
purple and swollen sublingual vein, slippery pulse or 
rough pulse. 
Inclusion Standard1
1. Meet the diagnostic criteria above-mentioned.  
2. SDS (Self-rating Depression Scale) score >50, 
Hemilton Depression Rating Scale (HAMD) score >7, 
PSQI score 8.  
3. Age between 18 and 75.  
4. With no intellectual or mental disorders, being able to 
self-judge the sleep condition and other common 
conditions, being able to accomplish the scale 
independently.  
5. Expected survival time being more than 3 months.  
6. Signing informed consent. 
Exclusion Standard 
1. With functional disorders of the heart, liver, kidney 
and spinal cord.  
2. Being incapable of understanding or accomplishing 
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the test due to dementia or low education level.  
3. Taking antidepressant drugs at the present time.  
4. Karnofsky score <30. 
Trial Suspension Standard 
1. During the observation period, appearing significant 
progress of the tumor and needing chemoradiotherapy or 
surgery.  
2. The patient refuses to continue to participate in the 
trial.  
3. With lower adherence to treatment, lost in follow-up.  
Table 1. Gender comparison of patients in the two 
groups 
Group  Cases Male Female 
Treatment group   40 26 14 
Control group   40 27 13 
Notes: Ȥ2 =0.0656, P>0.05. 
Table 2. Age comparison of patients in the two groups 
Group Cases Age (year) 
Treatment group 40 63.80±5.47 
Control group 40 63.60±4.26 
Notes: t=0.1441, P>0.05 
Table 3. Types of primary tumor in the two groups 




Pulmonary cancer 14 16 
Gastric cancer 8 8 
Breast cancer 3 4 
Colorectal cancer 9 5 
Lymphoma 3 1 
Cervical carcinoma 1 1 
Ovarian cancer 2 2 
Notes: Ȥ2 =0.1586, P>0.05 
Methods of Treatment 
Patients in the control group received Fluoxetine 
Hydrochloride Capsule (trade name: Prozac, produced by 
Patheon in France) 20 mg per day. In Treatment group, 
the patients were treated with acupuncture on the 
acupoints of Fenglong (ST 40), Yinlingquan (SP 9), 
Xuehai (SP 10), Sanyinjiao (SP 6), Yintang (EX-HN3), 
Baihui (DU 20), Sishencong (EX-HN1), Neiguan (PC 6) 
and Shenmen (TF 4). When needling, use the method of 
neutral supplementation and drainage. The patients were 
treated one time per day for 20–30 min, and the 
acupuncturist did needling manipulation at the interval of 
5–10 min. One course of treatment was 30 days.
Assessment Tools and Evaluation Standards 
1. Assessed depression conditions of patients in both 
groups before and after the treatment through SDS.7 2. 
Used HAMD of 17 points. Scores above 7 meant a 
possibility of depression; scores between 17 and 23
showed slight or moderate depression; and score above  
24 was severe depression. Used HAMD reduced rate to 
assess the therapeutic effectiveness.8 HAMD reduced 
rate (%) = (score before treatmentˉscore after treatment) 
/score before treatment × 100%, cure rate (reduced rate > 
75%), effective rate (reduced rate 50%–75%), improved 
rate (reduced rate 25%–49%), invalid rate (reduced rate 
<25%). 3. Used PSQI to assess sleep quality.9 Score 
between 8 and 12 showed slight insomnia; between 13 
and 17, moderate insomnia; and between 18 and 21, 
severe insomnia. Selected the patients with PSQI 8 and 
compared their scores before and after the treatment. 
Statistical Methods 
Use the software of SPSS11.5 and applied t test, 
Chi-square test and analysis of variance. P<0.05 was 
regarded as statistically difference, and P<0.01 was 
regarded as statistically significant difference. 
RESULTS 
SDS score results: before treatment, SDS scores of the 
treatment group and the control group were 64.12±5.34 
and 64.24±4.98 respectively. There was no significant 
difference (P>0.05). However, after treatment, SDS 
scores of the treatment group and the control group were 
43.64±5.28 and 50.76±5.42 respectively; which showed 
significant difference (P<0.05). The results indicated that 
acupuncture and Fluoxetine Hydrochloride capsule were 
both effective in relieving depression mood of patients 
suffering from malignant tumor; and the effectiveness of 
acupuncture was obviously higher. 
Table 4. SDS scores before and after treatment of 
malignant tumor patients in the two groups ( xfs)  
Group Cases Before Treatment After Treatment
Treatment group 40 64.12±5.34 43.64±5.28*# 
Control group 40 64.24±4.98 50.76±5.42** 
Notes: *compared with score before treatment P<0.05, #compared 
with the control group P<0.05; **compared with score before 
treatment P<0.05. 
HAMD score results: before treatment, HAMD scores of 
the treatment group and the control group were 
20.92±2.38 and 20.72±2.74 respectively. There was no 
significant difference (P>0.05). However, after treatment, 
HAMD scores of the treatment group and the control 
group were 9.88±1.27 and 13.72±2.05 respectively; 
which significant difference (P<0.05). The results 
indicated that acupuncture and Fluoxetine Hydrochloride 
capsule were both effective in relieving depression mood 
of patients suffering from malignant tumor; and the 
effectiveness of acupuncture was obviously higher. 
Table 5. HAMD scores before and after treatment of 
malignant tumor patients in the two groups ( xfs)
Group Cases Before Treatment After Treatment
Treatment group 40 20.92±2.38   9.88±1.27Ƹ#
Control group 40 20.72±2.74 13.72±2.05Ÿ
Notes: Ƹcompared with score before treatment P<0.05, #compared 
with the control group P<0.05; Ʒcompared with score before 
treatment, P<0.05. 
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Therapeutic evaluation results of depressed mood: After 
the treatment for 30 days, assessed therapeutic 
effectiveness according to the standards. In the treatment 
group, there were 3 patients being cured, 25 patients 
getting significant effectiveness, 7 patients being 
improved, and 5 patients getting no effect. The effective 
rate was 87.5% (35/40). In the control group, there was 
no patient being cured, 2 patients getting significant 
effectiveness, 25 patients being improved, and 13 
patients getting no effectiveness. The effective rate was 
67.5% (27/40). The treatment effectiveness in two groups 
was significantly different (Ȥ2=4.5878, P<0.05).  
PSQI score results: PSQI scores of the treatment group 
before and after treatment were 14.48±1.71 and 
7.92±1.22 respectively, the difference was significant 
(P<0.001) according to statistical analysis. For the 
control group, PSQI scores before and after treatment 
were 13.92±2.59 and 11.44±1.89 respectively, the 
difference was not significant (P>0.05) according to 
statistical analysis. The results indicated that acupuncture 
could improve the sleep quality of patients suffering 
from malignant tumor, and the effect was better than that 
of Fluoxetine Hydrochloride capsule.  
Table 6. PSQI total scores before and after treatment of 
malignant tumor patients in the two groups ( xfs)
Group Cases Before treatment After treatment
Treatment group 40 14.48±1.71  7.92±1.22ƾ# 
Control group 40 13.92±2.59 11.44±1.89 
Notes: ƾcompared with score before treatment P<0.05, #compared 
with control group P<0.01.
DISCUSSION 
Depression has a high incidence rate and recurrence rate 
in patients suffering from malignant tumor. It is very 
harmful, as the depressed mood affects patients’ sleep 
quality largely. With the development of cancer treatment 
and surgery methods, cancer mortality declines year by 
year. However, the depression morbidity is still high. 
Massie’s research indicated that the incidence rate of 
depression in cancer patients was 1%–50%; severe 
depression was 0–38%; and depression spectrum 
complications was 0–58%.10 Depression seriously affects 
the life quality of cancer patients and reduces patients’ 
adherence to treatment. Moreover, it affects the 
prognosis and increases the mortality. At the present time, 
fluoxertine hydrochloride is the antidepressant drug with 
exact effect and is applied widely in clinical practice. 
However, it also has adverse effects such as 
gastrointestinal symptoms, transient increase of anxiety 
symptoms and sexual disorder.11 Also, there are some 
limitations of clinical application. 
Some researches show that depression is related to 
hypofunction of norepinephrine and serotonin in the 
brain. Acupuncture can promote the releases of 
norepinephrine and serotonin; and can also help 
neurological rehabilitation. Thus, acupuncture has unique 
effect in treating depression.12,13 In addition, acupuncture 
has the effect of two-way regulation; it can adjust the 
processes of excitation and inhibition of cortical centre 
through nervous system and immune system; therefore, it 
can balance neurotransmitters among neuronal synapses 
in the brain. Furthermore, it can extend blood vessel, 
increase cerebral blood flow to improve depression and 
sleep quality.14
For malignant tumor, pattern of phlegm-stasis binding is 
the most common type in TCM.15 In the treatment group, 
all the patients were treated with acupuncture on the 
acupoints of Fenglong (ST 40), Yinlingquan (SP 9), 
Xuehai (SP 10), Sanyinjiao (SP 6), Yintang (EX-HN3), 
Baihui (DU 20), Sishencong (EX-HN1), Neiguan (PC 6) 
and Shenmen (TF 4). Acupuncture is mainly used to 
dissolve phlegm, dispel stasis, quiet the heart and calm 
the mind. Needling on Fenglong (ST 40) is to harmonize 
the stomach, dissolve phlegm and clear mind. Needling 
on Yinlingquan (SP 9) can take effects of resolving
dampness and dispelling stasis. Needling on Xuehai (SP 
10) is to regulate qi and invigorate blood. For depression, 
the location of disease is the heart and the brain. 
According to TCM, when the five zang-organs and six 
fu-organs get ill, their yuan-source (origin source) points 
will be chosen for needling. Thus, needling on Shenmen 
(TF 4), which is the yuan-source point of the 
Hand-Shaoyin Heart Channel, to quiet the heart and calm 
the mind; and combined with needling Sanyinjiao (SP 6) 
to fortify the spleen, sooth the liver and quiet the heart. 
In this way, sleep can be adjusted. Neiguan (PC 6) is the 
luo-connecting point of the Hand-Jueyin Pericardium 
Channel and one of confluence points of the eight 
extraordinary vessels, which communicates with Yinwei 
Mai (Yin linked Vessel) with the effects of quieting the 
heart, calming the mind, rectifying qi and relieving pain. 
One ancient TCM work Bai Zheng Fu (Essay for One 
Hundred Patterns) said: “Jianli (RN 11) and Neiguan (PC 
6) can dissolve all the discomforts in the chest.” 
Sishencong (EX-HN1), one extra point, can calm the 
mind. Baihui (DU 20) and Yintang (EX-HN3) can soothe 
the liver, rectify qi, quiet the heart and calm the mind; 
they also can improve the symptoms of depression. 
The research indicates that SDS score and HAMD score 
of the treatment group were 43.64±5.28 and 9.88±1.27 
respectively after 30 days treatment, which were 
obviously lower than 50.76±5.42 and 13.72±2.05 of the 
control group (P<0.05). In the treatment group, PSQI 
total score was 7.92±1.22 after 30 days treatment, which 
was obviously lower than 14.48±1.71 before treatment 
(P<0.05). The results showed that the effective rate was 
87.5% in the treatment group and 67.5% in the control 
group. The therapeutic effects in two groups were 
significantly different (P<0.05). In summary, 
acupuncture has a lot of advantages in treating 
depression of tumor patients; and it is favorable to 
relieving depression mood and improving sleep quality. 
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